tiprankstipranks
Trending News
More News >
Eastwood Bio-Medical Canada Inc (TSE:EBM)
:EBM
Canadian Market
Advertisement

Eastwood Bio-Medical Canada (EBM) Financial Statements

Compare
5 Followers

Eastwood Bio-Medical Canada Financial Overview

Eastwood Bio-Medical Canada's market cap is currently C$26.52M. The company's EPS TTM is C$-0.002; its P/E ratio is ―; Eastwood Bio-Medical Canada is scheduled to report earnings on June 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 702.08KC$ 867.94KC$ 1.30MC$ 981.05KC$ 718.34K
Gross ProfitC$ 454.39KC$ 440.51KC$ 902.74KC$ 458.37KC$ 213.31K
Operating IncomeC$ -437.70KC$ -506.04KC$ -128.76KC$ -590.89KC$ -838.66K
EBITDAC$ -342.05KC$ -410.58KC$ -32.33KC$ -495.50KC$ -744.32K
Net IncomeC$ -455.87KC$ -546.60KC$ -160.58KC$ -611.34KC$ -860.03K
Balance Sheet
Cash & Short-Term InvestmentsC$ 0.00C$ 18.45KC$ 39.84KC$ 20.87KC$ 122.66K
Total AssetsC$ 274.29KC$ 489.14KC$ 584.53KC$ 691.12KC$ 933.38K
Total DebtC$ 79.61KC$ 23.08KC$ 62.25KC$ 31.35KC$ 23.21K
Net DebtC$ 79.61KC$ 4.63KC$ 22.41KC$ 10.48KC$ -99.44K
Total LiabilitiesC$ 1.57MC$ 1.33MC$ 878.73KC$ 835.44KC$ 474.10K
Stockholders' EquityC$ -1.30MC$ -840.80KC$ -294.20KC$ -144.32KC$ 459.27K
Cash Flow
Free Cash FlowC$ -15.22KC$ -16.89KC$ -7.30KC$ -121.79KC$ -542.69K
Operating Cash FlowC$ -15.22KC$ -16.89KC$ -4.29KC$ -116.21KC$ -542.69K
Investing Cash FlowC$ 0.00C$ 0.00C$ -3.00KC$ -5.57KC$ 0.00
Financing Cash FlowC$ -4.62KC$ -4.50KC$ 26.27KC$ 20.00KC$ 40.00K
Currency in CAD

Eastwood Bio-Medical Canada Earnings and Revenue History

Eastwood Bio-Medical Canada Debt to Assets

Eastwood Bio-Medical Canada Cash Flow

Eastwood Bio-Medical Canada Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis